[HTML][HTML] Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings

F de Galiza Barbosa, MA Queiroz, RF Nunes, LB Costa… - Cancer Imaging, 2020 - Springer
PSMA PET imaging was originally used to assess biochemical recurrence of prostate cancer
(PCa), but its clinical use was promptly extended to detection, staging and therapy response …

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging

S Sheikhbahaei, A Afshar-Oromieh, M Eiber… - European journal of …, 2017 - Springer
Background The rapidly expanding clinical adaptation of prostate-specific membrane
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …

[HTML][HTML] Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

P Backhaus, B Noto, N Avramovic, LS Grubert… - European journal of …, 2018 - Springer
Background Prostate-specific membrane antigen (PSMA) is the up-and-coming target for
molecular imaging of prostate cancer. Despite its name, non-prostate-related PSMA …

[HTML][HTML] [68Ga] Ga-PSMA-11 in prostate cancer: a comprehensive review

F Bois, C Noirot, S Dietemann, IC Mainta… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …

68Ga-PSMA-HBED-CC uptake in cervical, celiac, and sacral ganglia as an important pitfall in prostate cancer PET imaging

C Rischpler, TI Beck, S Okamoto… - Journal of Nuclear …, 2018 - Soc Nuclear Med
The study aims to investigate the presence of physiologic prostate-specific membrane
antigen (68Ga-PSMA)-ligand uptake on PET in cervical, celiac, and sacral ganglia of the …

Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls

S Sheikhbahaei, RA Werner, LB Solnes… - Seminars in nuclear …, 2019 - Elsevier
The continuing adoption of prostate specific membrane antigen (PSMA)-targeted PET for
prostate cancer molecular imaging requires imagers and clinicians alike to be aware of the …

PET-CT in Clinical Adult Oncology—IV. Gynecologic and Genitourinary Malignancies

AE Salem, GC Fine, MF Covington, BR Koppula… - Cancers, 2022 - mdpi.com
Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT), has become a critical advanced imaging technique in oncology. With …

Reproducibility of PSMA PET/CT imaging for primary staging of treatment-naïve prostate cancer patients depends on the applied radiotracer: a retrospective study

MJ Hagens, DE Oprea-Lager, AN Vis… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Our purpose was to determine and compare the interobserver variability of 3 clinically
frequently used radiotracers targeting the prostate-specific membrane antigen (PSMA) …

Solitary rib lesions showing prostate‐specific membrane antigen (PSMA) uptake in pre‐treatment staging 68Ga‐PSMA‐11 positron emission tomography scans for …

MY Chen, A Franklin, J Yaxley, T Gianduzzo… - BJU …, 2020 - Wiley Online Library
Objectives To determine the proportion of solitary rib lesions on pre‐treatment 68Gallium‐
labelled prostate‐specific membrane antigen (PSMA)/computed tomography (CT) scans in …

Intense PSMA Uptake in a Vertebral Hemangioma Mimicking a Solitary Bone Metastasis in the Primary Staging of Prostate Cancer via 68Ga-PSMA PET/CT

F Gossili, CG Lyngby, V Løgager, HD Zacho - Diagnostics, 2023 - mdpi.com
A 78-year-old man with newly diagnosed high-risk prostate cancer underwent 68Ga-PSMA
PET/CT for primary staging. This showed a single, very intense PSMA uptake in the vertebral …